These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Reactivity with the EpCAM-specific antibodies MOC-31 and Ber-Ep4 in plasma cell neoplasms: a potential diagnostic pitfall in cytology samples. Weimholt RC, Sharifai N, Abro B, Vij K, Bernadt C. J Am Soc Cytopathol; 2019; 8(5):265-269. PubMed ID: 31103372 [Abstract] [Full Text] [Related]
23. Diagnostic usefulness of EMA, IMP3, and GLUT-1 for the immunocytochemical distinction of malignant cells from reactive mesothelial cells in effusion cytology using cytospin preparations. Ikeda K, Tate G, Suzuki T, Kitamura T, Mitsuya T. Diagn Cytopathol; 2011 Jun; 39(6):395-401. PubMed ID: 21574259 [Abstract] [Full Text] [Related]
25. The diagnostic utility of D2-40, calretinin, CK5/6, desmin and MOC-31 in the differentiation of mesothelioma from adenocarcinoma in pleural effusion cytology. Hyun TS, Barnes M, Tabatabai ZL. Acta Cytol; 2012 Jun; 56(5):527-32. PubMed ID: 23075894 [Abstract] [Full Text] [Related]
26. Identification of malignant cells in serous effusions using a panel of monoclonal antibodies Ber-EP4, MCA-b-12 and EMA. Stoop JA, Hendriks JG, Berends D. Cytopathology; 1992 Jun; 3(5):297-302. PubMed ID: 1288655 [Abstract] [Full Text] [Related]
27. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions. Friedman MT, Gentile P, Tarectecan A, Fuchs A. Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609 [Abstract] [Full Text] [Related]
29. Quality control of immunocytochemical staining of effusions using a standardized method of cell processing. Kuenen-Boumeester V, van Loenen P, de Bruijn EM, Henzen-Logmans SC. Acta Cytol; 1996 Oct; 40(3):475-9. PubMed ID: 8669182 [Abstract] [Full Text] [Related]
30. Distinction of mesothelioma from carcinoma in pleural effusions. An immunocytochemical study on routinely processed cytoblock preparations. Kuhlmann L, Berghäuser KH, Schäffer R. Pathol Res Pract; 1991 May; 187(4):467-71. PubMed ID: 1876528 [Abstract] [Full Text] [Related]
31. Comparison of three cytologic preparation methods and immunocytochemistries to distinguish adenocarcinoma cells from reactive mesothelial cells in serous effusion. Ueda J, Iwata T, Ono M, Takahashi M. Diagn Cytopathol; 2006 Jan; 34(1):6-10. PubMed ID: 16355377 [Abstract] [Full Text] [Related]
37. Diagnostic Accuracy of a Limited Immuno-panel of Calretinin and Ber-EP4 for Diagnosis of Malignant Effusions. Khurram N, Anis T, Yusuf NW. J Coll Physicians Surg Pak; 2019 Jan; 29(1):33-36. PubMed ID: 30630566 [Abstract] [Full Text] [Related]
38. Diagnostic Value of Claudin-4 and EZH2 Immunohistochemistry in Effusion Cytology. Elhosainy A, Hafez MMA, Yassin EH, Adam M, Elnaggar MS, Aboulhagag NA. Asian Pac J Cancer Prev; 2022 Aug 01; 23(8):2779-2785. PubMed ID: 36037134 [Abstract] [Full Text] [Related]
40. Utility of BER-EP4 in the diagnosis of adenocarcinoma in effusions: an immunocytochemical study of 232 cases. Diaz-Arias AA, Loy TS, Bickel JT, Chapman RK. Diagn Cytopathol; 1993 Oct 01; 9(5):516-21. PubMed ID: 8287759 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]